Photocatalytic degradation of fluoroquinolone antibiotics using chitosan biopolymer functionalized copper oxide nanoparticles prepared by facile sonochemical method.

Photocatalytic degradation is an excellent method for removing pharmaceutical residues due to their simplicity, ecological benignity, high efficiency, and exceptional stability. Herein, we demonstrate the sonochemically synthesised chitosan biopolymer functionalized copper oxide nanoparticles as an efficient photocatalyst for the degradation of fluoroquinolone-based antibiotics. The X-ray diffraction Rietveld refinement revealed the formation of single-phase copper oxide (CuO) with a monoclinic structure. The presence of biopolymer functionalization was corroborated by Fourier Transform Infrared spectroscopy by observing the -NH2 and -OH functional groups. The high-resolution transmission electron microscopic images inferred that Chitosan functionalized copper oxide (C-CuO) particles are nano-sized with a smooth texture and aggregation-free particles. The strong absorbance and the broad photoluminescence emission in the ultraviolet-visible region confirm the suitability of CuO and C-CuO nanoparticles for photocatalytic applications. The catalytic activity was studied against fluoroquinolone-based antibiotics such as ciprofloxacin and norfloxacin under direct sunlight illumination. Interestingly, the C-CuO catalyst demonstrated 71.07 % (@140 min.) and 71.9 % (@60 min.) of degradation for ciprofloxacin and norfloxacin, respectively. The obtained photocatalytic activity of the prepared CuO and C-CuO catalysts was superior to the CuO particles prepared by the coprecipitation method (CC-CuO).

Prodigiosin production from Serratia marcescens strain CSK and their antioxidant, antibacterial, cytotoxic effect and in silico study of caspase-3 apoptotic protein.

The present study emphasizes the production and optimization of prodigiosin (PG) pigment from Serratia marcescens strain CSK, which was isolated from Shevaroy Hills, Salem district, Tamil Nadu, India. The response surface methodology analysis was applied for the optimization process of PG production. The maximum production of PG (2950 mg/L) was obtained at pH 7.0 with the addition of tryptophan (4.0 g/L) and sucrose (3.0 g/L) with 60 h of incubation. Further, the PG was characterized using high-performance liquid chromatography, Fourier-transform infrared spectroscopy, and gas chromatography-mass spectrometry. The purified PG exhibited strong antioxidant and antibacterial activities. Also, PG's cytotoxic effects against human breast cancer (MCF-7) cells were observed through acridine orange-ethidium bromide (AO-EB) and Hoechst staining. Molecular dockingstudies revealed that PG could bind positively to the caspase-3 (breast cancer protein 1RE1) binding site with a binding energy score of 17.37 kcal/mol. Overall, the novel PG was found to be an anticancer drug for potential applications in the pharmaceutical industry.

In vitro susceptibility of filamentous fungi from mycotic keratitis to azole drugs.

OBJECTIVE: The in vitro antifungal activities of azole drugs viz., itraconazole, voriconazole, ketoconazole, econazole and clotrimazole were investigated in order to evaluate their efficacy against filamentous fungi isolated from mycotic keratitis. METHODS: The specimen collection was carried out from fungal keratitis patients attending Aravind eye hospital and Post-graduate institute of ophthalmology, Coimbatore, India and was subsequently processed for the isolation of fungi. The dilutions of antifungal drugs were prepared in RPMI 1640 medium. Minimum inhibitory concentrations (MICs) were determined and MIC50 and MIC90 were calculated for each drug tested. RESULTS: A total of 60 fungal isolates were identified as Fusarium spp. (n=30), non-sporulating moulds (n=9), Aspergillus flavus (n=6), Bipolaris spp. (n=6), Exserohilum spp. (n=4), Curvularia spp. (n=3), Alternaria spp. (n=1) and Exophiala spp. (n=1). The MICs of ketoconazole, clotrimazole, voriconazole, econazole and itraconazole for all the fungal isolates ranged between 16 µg/mL and 0.03 µg/mL, 4 µg/mL and 0.015 µg/mL, 8 µg/mL and 0.015 µg/mL, 8 µg/mL and 0.015 µg/mL and 32 µg/mL and 0.06 µg/mL respectively. From the MIC50 and MIC90 values, it could be deciphered that in the present study, clotrimazole was more active against the test isolates at lower concentrations (0.12-5 µg/mL) when compared to other drugs tested. CONCLUSION: The results suggest that amongst the tested azole drugs, clotrimazole followed by voriconazole and econazole had lower MICs against moulds isolated from mycotic keratitis.